ABCG2 inhibitors (NCI)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameABCG2 inhibitors (NCI)
Drug Alias NameTM-1 peptide (NCI)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionBroad substrate specificity ATP-binding cassette transporter ABCG2 inhibitors
TargetsBroad substrate specificity ATP-binding cassette transporter ABCG2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNational Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Cancer Institute
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A